Study of retinal and optic nerve ganglion cell layer in Parkinson’s disease and asymptomatic carriers of the LRRK2-G2019S mutation
Objective: To study whether retinal nerve alterations can be a useful biomarker in presymptomatic stages of Parkinson's disease (PD) associated with the G2019S mutation of…Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature
Objective: This study assessed kinematic profiles of individuals with Parkinson’s on and off dopaminergic medication to investigate whether the effect of dopaminergic modulation on speed…Polymorphisms in Prosaposin gene are associated with familial and early-onset Parkinson’s disease: A case-control association study and meta-analysis
Objective: To investigate the role of the PSAP gene in PD patients in Taiwan, including familial PD and early-onset Parkinson’s disease. Background: Mutations in the…Intestinal microbial dysbiosis promotes prebiotic-reversible inflammation in Parkinson’s disease
Objective: To determine the functional effects of disrupted intestinal microbiota in Parkinson’s disease (PD), particularly the impacts of dysbiosis on inflammation, neuroprotective hormone secretion, and…Design of the Remote Optimization Adjustment and Measurement for Deep Brain Stimulation (ROAM-DBS) Randomized Controlled Trial Using Decentralized Patient Monitoring
Objective: To describe the design of the ROAM-DBS trial which measures outcomes of remote programming using remote monitoring. Background: A third of Parkinson’s Disease (PD)…‘Top of the POPPS’ – how we set up an online support group for Partners of People with Parkinson’s.
Objective: To provide useful peer and professional support for partners of people with Parkinson's (PWP)To be able to offer that support in a Covid safe…A qualitative study exploring the treatment burden and capacity of people with Parkinson’s and their caregivers
Objective: To explore experiences of treatment burden and capacity in Parkinson’s and identify potentially modifiable factors that can improve this Background: Treatment burden, the workload…Lymphocyte count/neutrophil-to-lymphocyte ratio and mild cognitive impairment in Parkinson’s disease
Objective: The present study aimed to elucidate whether i) lymphocyte count and neutrophil-to-lymphocyte ratio (NLR) can discriminate Parkinson's disease (PD) patients from healthy controls (HC);…Developing zebrafish CRISPR/Cas9 knockout models of Parkinson’s Disease to identify novel therapeutic targets.
Objective: Human patients present punctual mutations and/or small deletions in genes that have been associated with Parkinson’s disease, namely, park1, park2, park6, park7, and park8.…No evidence for the impact of SNCA rs356219 on Parkinson’s disease progression
Objective: To replicate findings from previous studies reporting an association between the α-synuclein (SNCA) rs356219 genetic variant and progression to key outcomes in Parkinson’s disease…
- « Previous Page
- 1
- …
- 236
- 237
- 238
- 239
- 240
- …
- 338
- Next Page »